IRIS
RONCATO, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 845
EU - Europa 496
AS - Asia 416
SA - Sud America 84
AF - Africa 20
Totale 1.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 832
SG - Singapore 251
IT - Italia 117
RU - Federazione Russa 88
BR - Brasile 76
DE - Germania 58
CN - Cina 48
IE - Irlanda 45
KR - Corea 40
FR - Francia 30
GB - Regno Unito 29
HK - Hong Kong 27
FI - Finlandia 24
IN - India 22
NL - Olanda 19
UA - Ucraina 17
CH - Svizzera 16
TG - Togo 15
AT - Austria 14
CZ - Repubblica Ceca 11
TR - Turchia 9
CA - Canada 8
ES - Italia 7
SE - Svezia 6
AR - Argentina 3
BE - Belgio 3
IQ - Iraq 3
LT - Lituania 3
MX - Messico 3
BD - Bangladesh 2
DK - Danimarca 2
OM - Oman 2
PL - Polonia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
IL - Israele 1
IR - Iran 1
KZ - Kazakistan 1
MA - Marocco 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 1.861
Salva come PNG Salva come JPEG
Città #
Singapore 186
Boardman 75
Fairfield 69
Chandler 68
Ashburn 63
Dublin 45
Seoul 40
Houston 38
Woodbridge 38
Cambridge 32
Seattle 30
Wilmington 27
Hong Kong 26
Los Angeles 24
Zurich 16
Lomé 15
Munich 15
Nuremberg 15
Ann Arbor 14
London 14
Beijing 13
Dearborn 13
Frankfurt am Main 12
Ogden 12
Pune 12
Genoa 11
Brno 10
Dallas 10
Helsinki 9
Princeton 9
Arezzo 8
Redmond 8
Amsterdam 7
Hyderabad 7
Lauterbourg 7
Santa Clara 7
São Paulo 7
Turku 7
Vienna 7
Jacksonville 6
New York 6
Portsmouth 6
Udine 6
Belluno 5
Brooklyn 5
Des Moines 5
Düsseldorf 5
Lappeenranta 5
Milan 5
Belo Horizonte 4
Cormons 4
Deiva Marina 4
Izmir 4
Xi'an 4
Zoppola 4
Brasília 3
Brussels 3
Codroipo 3
Cologne 3
Guangzhou 3
Guarulhos 3
Madrid 3
Naples 3
Shenzhen 3
Thetford 3
Toronto 3
Azzano Decimo 2
Bologna 2
Boston 2
Charlotte 2
Gorgonzola 2
Innsbruck 2
Leawood 2
Lissone 2
Mirano 2
Monza 2
Muscat 2
Newark 2
Novara 2
Porcia 2
Rio de Janeiro 2
Riyadh 2
Roccamonfina 2
Romans d'Isonzo 2
Rome 2
San Diego 2
San Francisco 2
San Giorgio di Nogaro 2
Stockholm 2
Tashkent 2
Tulle 2
Urbino 2
Vaestra Froelunda 2
Venice 2
Vercelli 2
Volta Redonda 2
Abidjan 1
Ahmedabad 1
Almaty 1
Ananindeua 1
Totale 1.201
Salva come PNG Salva come JPEG
Nome #
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC) 126
Estimating the Effectiveness of DPYD Genotyping in Italian Individuals Suffering from Cancer Based on the Cost of Chemotherapy-Induced Toxicity 104
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 93
The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines 83
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 76
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer? 64
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 57
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 53
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 49
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer 47
Rare genetic variant burden in DPYD predicts severe fluoropyrimidine-related toxicity risk 45
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 44
JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future 40
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure 39
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study 39
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 39
Abstract PD10-01: Impact of ESR1 mutations on Selective Estrogen Receptor Degraders and Modulators: an integrated liquid-biopsy and pharmacodynamics approach 37
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients 37
A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients 36
Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype 35
The challenge of molecular selection in liver-limited metastatic colorectal cancer for surgical resection: a systematic review and meta-analysis in the context of current and future approaches 35
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm 34
Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy 33
Lipid rafts as viral entry routes and immune platforms: A double-edged sword in SARS-CoV-2 infection? 31
Implementation of preemptive testing of a pharmacogenomic panel in clinical practice: Where do we stand? 31
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome 30
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 29
New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach 28
Pharmacovigilance, drug interactions, pharmacogenetics and therapeutic drug monitoring of anticancer agents: a valuable support for clinical practice 28
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways 28
Pharmacogenetic score predicts overall survival, progression-free survival and platinum sensitivity in ovarian cancer 27
European association for clinical pharmacology and therapeutics young clinical pharmacologists working group: a cornerstone for the brighter future of clinical pharmacology 26
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 26
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 26
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS) 26
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 26
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 25
Pregnane X receptor, constitutive androstane receptor and hepatocyte nuclear factors as emerging players in cancer precision medicine 25
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 25
Correction: Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy (Cell Death & Disease, (2022), 13, 4, (398), 10.1038/s41419-022-04741-9) 25
Body mass index impacts adverse events and drug plasma concentration: should dose intensity be included in the palbociclib equation? 25
Inositol and Non-Alcoholic Fatty Liver Disease: A Systematic Review on Deficiencies and Supplementation 25
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma 24
Genetic biomarkers for hepatocellular cancer risk in a caucasian population 24
Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice 23
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 22
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 21
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients 21
Improving decision making on DPYD and UGT1A1*28 patients' profiling with an innovative reimbursement strategy 20
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity 20
CDK4/6 Inhibitors in Breast Cancer Treatment: Potential Interactions with Drug, Gene, and Pathophysiological Conditions 20
Clinical Benefits and Utility of Pretherapeutic DPYD and UGT1A1 Testing in Gastrointestinal Cancer 19
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment 19
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring 17
Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation 16
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug–gene interactions 15
Cost-utility analysis and cross-country comparison of pharmacogenomics-guided treatment in colorectal cancer patients participating in the U-PGx PREPARE study 13
mHealth Apps Available in Italy to Support Health Care Professionals in Antimicrobial Stewardship Implementation: Systematic Search in App Stores and Content Analysis 4
Totale 2.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.302
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 0 0 0 0 3 5
2020/2021127 3 6 19 16 8 11 28 11 8 5 7 5
2021/202266 3 5 0 4 2 2 11 0 4 10 14 11
2022/2023318 9 3 4 77 59 70 0 22 45 4 9 16
2023/2024339 31 19 11 4 39 40 21 15 19 31 25 84
2024/2025975 53 87 42 40 88 71 91 61 126 100 216 0
Totale 2.055